NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Deferred Tax Assets, Gross in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2016 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Deferred Tax Assets, Gross for the quarter ending September 30, 2024 was $19.2M, a 22.6% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.2M +$3.53M +22.6% Sep 30, 2024 10-K 2024-12-17
Q3 2023 $15.6M +$3.58M +29.6% Sep 30, 2023 10-K 2024-12-17
Q3 2022 $12.1M +$3.19M +35.9% Sep 30, 2022 10-K 2023-12-15
Q3 2021 $8.87M +$3.18M +55.8% Sep 30, 2021 10-K 2022-12-22
Q3 2020 $5.69M +$1.74M +44.1% Sep 30, 2020 10-K/A 2022-05-31
Q3 2019 $3.95M +$1.84M +86.8% Sep 30, 2019 10-K 2020-12-09
Q3 2018 $2.12M Sep 30, 2018 10-K 2019-12-20
Q4 2017 $1.11M +$1M +943% Dec 31, 2017 10-KT/A 2019-03-18
Q4 2016 $106K Dec 31, 2016 10-K 2018-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.